NCT02793882View on ClinicalTrials.gov

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

218

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 25, 2017

Study Completion Date

April 24, 2017

Conditions
Prostate Cancer
Interventions
DRUG

18F-Fluorocholine PET/CT

Trial Locations (1)

H3T1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

NCT02793882 - Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer | Biotech Hunter | Biotech Hunter